Interstitial Lung Disease

Lung Disease

Interstitial Lung Disease

What is Interstitial Lung Disease?

Interstitial lung disease is an umbrella term used to categorize over 100 different types of pulmonary disorders that affect the absorption of oxygen into the lungs. It includes a diverse collection of illnesses with a variety of causes, treatments and prognoses. Individuals who suffer from interstitial lung disease often have difficulty breathing and moving from place to place due to a consistent feeling of shortness of breath. Disorders classified under interstitial lung disease are often characterized by scarring of the lung’s delicate tissues and a dry, pestering cough.

There are a variety of causes of interstitial lung disease that range in diversity.

However,  interstitial lung disease may also develop without a known cause, and in that case it is known as idiopathic. The most common form of idiopathic interstitial lung disease is pulmonary fibrosis. As interstitial lung disease is a progressive disorder, identifying a known cause for the disease is especially important. Due to the fact that interstitial lung disease can be caused by environmental factors, removing these triggers may slow the progression of the disease and damage to the lungs. If the disease is idiopathic, cellular therapy for lung disease, and other forms of regenerative medicine have been found beneficial.

 

Because interstitial lung disease can develop without a known cause, everyone faces the potential risk of developing one of the diseases in this category. Men, women and children of all ages can potentially develop some form of ILD. Those afflicted with autoimmune diseases such as lupus, rheumatoid arthritis and scleroderma have an above average risk.

Individuals who have been exposed to environmental contaminants such as asbestos, and coal, cotton and silica dust also have a higher probability of developing interstitial lung disease. Other known causes include cigarette smoking and various types of radiation therapy.

If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

Penny K

 

Penny K. | Omaha, NE | COPD & Emphysema

“I can go to church and sing! It’s wonderful!”

Related Posts

  • Three months after Barbara’s cellular therapy she noticed she could climb a flight of stairs or walk up to a mile – near impossibilities before her therapy. Read more
  • interstitial-lung-disease_-stages-prognosis-and-treatmentA diagnosis of ILD can be a devastating event, sparking confusion, further questions, and a putting you at a loss of trying to figure out what’s next. With your health ... Read more

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.